Search Results - "YONEDA, FUMIO"

Refine Results
  1. 1

    Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25–35) by Tsunekawa, Hiroko, Noda, Yukihiro, Mouri, Akihiro, Yoneda, Fumio, Nabeshima, Toshitaka

    Published in Behavioural brain research (19-07-2008)
    “…Selegiline, an irreversible inhibitor of monoamine oxidase B used in the treatment of Parkinson's disease, has been demonstrated to have a potential…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Retinal Neuronal Death Induced by Intraocular Administration of a Nitric Oxide Donor and Its Rescue by Neurotrophic Factors in Rats by Takahata, Kazue, Katsuki, Hiroshi, Kume, Toshiaki, Nakata, Daisuke, Ito, Ken, Muraoka, Shizuko, Yoneda, Fumio, Kashii, Satoshi, Honda, Yoshihito, Akaike, Akinori

    “…To investigate the neurotoxic outcome in the rat retina exposed to nitric oxide (NO) released from an NO donor and to evaluate the effects of neurotrophic…”
    Get full text
    Journal Article
  4. 4

    Effects of ( R)-(−)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(−)-BPAP] in animal models of mood disorders by Tsunekawa, Hiroko, Noda, Yukihiro, Miyazaki, Masayuki, Yoneda, Fumio, Nabeshima, Toshitaka, Wang, Dayong

    Published in Behavioural brain research (16-05-2008)
    “…( R)-(−)-1-(Benzofuran-2-yl)-2-propylaminopentane hydrochloride [(−)-BPAP] is a highly potent enhancer of impulse propagation-mediated monoamine release and an…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Antidiabetic and adipogenic properties in a newly synthesized thiazolidine derivative, FPFS-410 by Norisada, Nobuyoshi, Masuzaki, Hiroaki, Fujimoto, Muneya, Inoue, Gen, Hosoda, Kiminori, Hayashi, Tatsuya, Watanabe, Mayumi, Muraoka, Shizuko, Yoneda, Fumio, Nakao, Kazuwa

    Published in Metabolism, clinical and experimental (01-12-2004)
    “…We report here a newly synthesized cyanoimino-oxothiazolidine derivative, FPFS-410, which has properties to ameliorate both hyperglycemia and dyslipidemia…”
    Get full text
    Journal Article
  7. 7

    (−)1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain by Knoll, Joseph, Yoneda, Fumio, Knoll, Berta, Ohde, Hironori, Miklya, Ildikó

    Published in British journal of pharmacology (01-12-1999)
    “…The brain constituents β‐phenylethylamine (PEA) and tryptamine enhance the impulse propagation mediated transmitter release (exocytosis) from the…”
    Get full text
    Journal Article
  8. 8

    Enhancer substances: Selegiline and R-(–)-1-(benzofuran-2-yl)-2-propylaminopentane [(–)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes by Shimazu, Seiichiro, Tanigawa, Akie, Sato, Noriyuki, Yoneda, Fumio, Hayashi, Kyozo, Knoll, Joseph

    Published in Life sciences (1973) (02-05-2003)
    “…R-(–)-1-(Benzofuran-2-yl)-2-propylaminopentane [(–)-BPAP] is a potent “catecholaminergic and serotonergic activity enhancer (CAE/SAE)”, which enhances the…”
    Get full text
    Journal Article
  9. 9

    Effects of R-(−)-BPAP on the Expressions of Neurotrophins and Their Receptors in Mesencephalic Slices by Hirami, Chieko, Takahata, Kazue, Shimazu, Seiichiro, Yoneda, Fumio, Hayashi, Kyozo, Katsuki, Hiroshi, Akaike, Akinori

    Published in Biological & pharmaceutical bulletin (01-08-2005)
    “…R-(−)-1-(Benzofuran-2-yl)-2-propylaminopentane [R-(−)-BPAP] enhances electric field stimulation-induced release of catecholamine from isolated brain stem and…”
    Get full text
    Journal Article
  10. 10

    Retinal Neurotoxicity of Nitric Oxide Donors With Different Half-Life of Nitric Oxide Release: Involvement of N-Methyl- D -aspartate Receptor by Takahata, Kazue, Katsuki, Hiroshi, Kume, Toshiaki, Ito, Ken, Tochikawa, Yoshinaga, Muraoka, Shizuko, Yoneda, Fumio, Kashii, Satoshi, Honda, Yoshihito, Akaike, Akinori

    Published in Journal of Pharmacological Sciences (01-08-2003)
    “…We compared the degree of neurotoxic outcome in the retina exposed to three nitric oxide (NO) donors with different half-life of NO release. Intravitreal…”
    Get full text
    Journal Article
  11. 11

    The novel catecholaminergic and serotoninergic activity enhancer R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes by Ohta, Kiyoe, Ohta, Mitsuhiro, Mizuta, Ikuko, Fujinami, Aya, Shimazu, Seiichiro, Sato, Noriyuki, Yoneda, Fumio, Hayashi, Kyozo, Kuno, Sadako

    Published in Neuroscience letters (16-08-2002)
    “…We investigated the effects of the novel catecholaminergic and serotoninergic activity enhancer R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane ((−)-BPAP) on…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    DNA Oligomers Having a Diazapyrenium Dication (DAP2+); Synthesis and DNA Cleavage Activities by IKEDA, Hisafumi, FUJI, Kaoru, TANAKA, Kiyoshi, ISO, Yasuyoshi, YONEDA, Fumio

    Published in Chemical & pharmaceutical bulletin (01-10-1999)
    “…Aiming at the creation of functionalized antisense DNA oligomers possessing site-selective DNA cleaving activity, viologen and a related compound,…”
    Get full text
    Journal Article
  15. 15

    Effects of R-(-)-BPAP on the Expressions of Neurotrophins and Their Receptors in Mesencephalic Slices by Chieko HIRAMIa, Kazue TAKAHATAa, Seiichiro SHIMAZUa, Fumio YONEDAa, Kyozo HAYASHIb, Hiroshi KATSUKIc, Akinori AKAIKEc

    “…R-(-)-1-(Benzofuran-2-yl)-2-propylaminopentane [R-(-)-BPAP] enhances electric field stimulation-induced release of catecholamine from isolated brain stem and…”
    Get full text
    Journal Article
  16. 16

    Synthesis and evaluation of nitro 5-deazaflavins as novel bioreductive antitumor agents by Kawamoto, Tetsuji, Ikeuchi, Yoshihiro, Hiraki, Junko, Eikyu, Yoshiteru, Shimizu, Kazue, Tomishima, Masaki, Bessho, Kiyoshi, Yoneda, Fumio, Mikata, Yuji, Nishida, Mamiko, Ikehara, Kenji, Sasaki, Takuma

    Published in Bioorganic & medicinal chemistry letters (21-09-1995)
    “…A series of nitro 5-deazaflavins, 5-deazaflavins possessing a nitro group at C(6)–C(9) position, has been designed and synthesized as a novel class of…”
    Get full text
    Journal Article
  17. 17

    Simple New Method for the Synthesis of 5-Deaza-10-oxaflavin, a Potential Organic Oxidant by CHEN, Xing, TANAKA, Kiyoshi, YONEDA, Fumio

    “…Several 5-deaza-10-oxaflavin (2H-chromeno[2, 3-d]pyrimidine-2, 4(3H)dione) derivatives (1) were prepared in satisfactory yields through new, practical routes…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Antidepressant-like effects of selegiline in the forced swim test by Shimazu, Seiichiro, Minami, Akiko, Kusumoto, Haruko, Yoneda, Fumio

    Published in European neuropsychopharmacology (01-10-2005)
    “…Although selegiline, a monoamine oxidase (MAO)-B inhibitor, is reported to exert antidepressant effects in depressant patients, evidence in rodents for effects…”
    Get full text
    Journal Article
  20. 20

    Effects of selegiline alone or with donepezil on memory impairment in rats by Takahata, Kazue, Minami, Akiko, Kusumoto, Haruko, Shimazu, Seiichiro, Yoneda, Fumio

    Published in European journal of pharmacology (22-08-2005)
    “…Selegiline, a monoamine oxidase-B inhibitor, is reported to improve memory and learning in dementia of Alzheimer's type. However, only a few studies have…”
    Get full text
    Journal Article